These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
484 related articles for article (PubMed ID: 27043496)
1. Preliminary LC-MS Based Screening for Inhibitors of Plasmodium falciparum Thioredoxin Reductase (PfTrxR) among a Set of Antimalarials from the Malaria Box. Tiwari NK; Reynolds PJ; Calderón AI Molecules; 2016 Mar; 21(4):424. PubMed ID: 27043496 [TBL] [Abstract][Full Text] [Related]
2. Specific inhibitors of Plasmodium falciparum thioredoxin reductase as potential antimalarial agents. Andricopulo AD; Akoachere MB; Krogh R; Nickel C; McLeish MJ; Kenyon GL; Arscott LD; Williams CH; Davioud-Charvet E; Becker K Bioorg Med Chem Lett; 2006 Apr; 16(8):2283-92. PubMed ID: 16458512 [TBL] [Abstract][Full Text] [Related]
3. Plasmodium falciparum Thioredoxin Reductase (PfTrxR) and Its Role as a Target for New Antimalarial Discovery. McCarty SE; Schellenberger A; Goodwin DC; Fuanta NR; Tekwani BL; Calderón AI Molecules; 2015 Jun; 20(6):11459-73. PubMed ID: 26111176 [TBL] [Abstract][Full Text] [Related]
4. Identification of oleamide in Guatteria recurvisepala by LC/MS-based Plasmodium falciparum thioredoxin reductase ligand binding method. Munigunti R; Nelson N; Mulabagal V; Gupta MP; Brun R; Calderón AI Planta Med; 2011 Oct; 77(15):1749-53. PubMed ID: 21567357 [TBL] [Abstract][Full Text] [Related]
5. Determination of antiplasmodial activity and binding affinity of curcumin and demethoxycurcumin towards PfTrxR. Munigunti R; Gathiaka S; Acevedo O; Sahu R; Tekwani B; Calderón AI Nat Prod Res; 2014; 28(6):359-64. PubMed ID: 24443991 [TBL] [Abstract][Full Text] [Related]
6. Development of liquid chromatography/mass spectrometry based screening assay for PfTrxR inhibitors using relative quantitation of intact thioredoxin. Munigunti R; Calderón AI Rapid Commun Mass Spectrom; 2012 Sep; 26(17):2051-6. PubMed ID: 22847705 [TBL] [Abstract][Full Text] [Related]
7. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex. Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423 [TBL] [Abstract][Full Text] [Related]
8. Double-drug development against antioxidant enzymes from Plasmodium falciparum. Biot C; Dessolin J; Grellier P; Davioud-Charvet E Redox Rep; 2003; 8(5):280-3. PubMed ID: 14962365 [TBL] [Abstract][Full Text] [Related]
9. Crystal structure of Plasmodium falciparum thioredoxin reductase, a validated drug target. Boumis G; Giardina G; Angelucci F; Bellelli A; Brunori M; Dimastrogiovanni D; Saccoccia F; Miele AE Biochem Biophys Res Commun; 2012 Sep; 425(4):806-11. PubMed ID: 22889878 [TBL] [Abstract][Full Text] [Related]
10. Antimalarial activity of Malaria Box Compounds against Plasmodium falciparum clinical isolates. Chirawurah JD; Ansah F; Nyarko PB; Duodu S; Aniweh Y; Awandare GA Int J Parasitol Drugs Drug Resist; 2017 Dec; 7(3):399-406. PubMed ID: 29128848 [TBL] [Abstract][Full Text] [Related]
11. Development of a functional assay to detect inhibitors of Plasmodium falciparum glutathione reductase utilizing liquid chromatography-mass spectrometry. Burkard L; Scheuermann A; Simithy J; Calderón AI Biomed Chromatogr; 2016 Apr; 30(4):543-7. PubMed ID: 26257195 [TBL] [Abstract][Full Text] [Related]
12. Discovery and biochemical characterization of Plasmodium thioredoxin reductase inhibitors from an antimalarial set. Theobald AJ; Caballero I; Coma I; Colmenarejo G; Cid C; Gamo FJ; Hibbs MJ; Bass AL; Thomas DA Biochemistry; 2012 Jun; 51(23):4764-71. PubMed ID: 22612231 [TBL] [Abstract][Full Text] [Related]
13. Screening of natural compounds for ligands to PfTrxR by ultrafiltration and LC-MS based binding assay. Munigunti R; Mulabagal V; Calderón AI J Pharm Biomed Anal; 2011 May; 55(2):265-71. PubMed ID: 21353756 [TBL] [Abstract][Full Text] [Related]
14. Identification of β-hematin inhibitors in the MMV Malaria Box. Fong KY; Sandlin RD; Wright DW Int J Parasitol Drugs Drug Resist; 2015 Dec; 5(3):84-91. PubMed ID: 26150923 [TBL] [Abstract][Full Text] [Related]
15. Plasmodium falciparum Resistance to a Lead Benzoxaborole Due to Blocked Compound Activation and Altered Ubiquitination or Sumoylation. Sindhe KMV; Wu W; Legac J; Zhang YK; Easom EE; Cooper RA; Plattner JJ; Freund YR; DeRisi JL; Rosenthal PJ mBio; 2020 Jan; 11(1):. PubMed ID: 31992618 [TBL] [Abstract][Full Text] [Related]
16. Intersubunit interactions in Plasmodium falciparum thioredoxin reductase. Krnajski Z; Gilberger TW; Walter RD; Muller S J Biol Chem; 2000 Dec; 275(52):40874-8. PubMed ID: 11022050 [TBL] [Abstract][Full Text] [Related]
17. Identification of Wang X; Miyazaki Y; Inaoka DK; Hartuti ED; Watanabe YI; Shiba T; Harada S; Saimoto H; Burrows JN; Benito FJG; Nozaki T; Kita K Genes (Basel); 2019 Jun; 10(6):. PubMed ID: 31234346 [TBL] [Abstract][Full Text] [Related]
18. Screening the Medicines for Malaria Venture Pathogen Box for invasion and egress inhibitors of the blood stage of Plasmodium falciparum reveals several inhibitory compounds. Dans MG; Weiss GE; Wilson DW; Sleebs BE; Crabb BS; de Koning-Ward TF; Gilson PR Int J Parasitol; 2020 Mar; 50(3):235-252. PubMed ID: 32135179 [TBL] [Abstract][Full Text] [Related]
19. Structural model of the Plasmodium falciparum thioredoxin reductase:a novel target for antimalarial drugs. Banerjee AK; Arora N; Murty US J Vector Borne Dis; 2009 Sep; 46(3):171-83. PubMed ID: 19724080 [TBL] [Abstract][Full Text] [Related]
20. Helicases - feasible antimalarial drug target for Plasmodium falciparum. Tuteja R FEBS J; 2007 Sep; 274(18):4699-704. PubMed ID: 17824956 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]